FDA 483 - Deserving Health International Corp - July 14, 2017

Deserving Health International Corp in Richmond was cited for numerous deficiencies during an FDA inspection, primarily concerning its manufacturing of OTC drug products, including penicillin-containing homeopathic drugs and sterile eye drops. The firm demonstrated a widespread lack of validated processes, inadequate quality control, insufficient product testing, and poor documentation across various operations. These issues indicate a systemic failure to comply with cGMP requirements, raising significant concerns about product quality, sterility, and overall patient safety.